OSOS Holding Group Company K.P.S.C. (KWSE:OSOS)

Ligand Pharmaceuticals Income Statement

Financials in millions KWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Rental Revenue	0.97	0.75	0.47	0.45	0.3	0.45
Other Revenue	-	-	-	-	-0.07	0.02
Total Revenue	0.97	0.75	0.47	0.45	0.23	0.47
Revenue Growth (YoY	93.26%	57.17%	4.73%	96.32%	-50.80%	-37.51%
Property Expenses	0.11	0.07	0.06	0.08	0.04	0.03
Selling, General & Administrative	0.73	0.64	0.54	0.53	0.52	0.43
Other Operating Expenses	0.04	0.06	0.02	0.01	0.04	-
Total Operating Expenses	0.2	0.73	0.63	0.62	0.61	0.57
Operating Income	0.77	0.02	-0.16	-0.16	-0.38	-0.1
Interest Expense	-0.21	-0.16	-0.07	-0.06	-0.01	-
Interest & Investment Income	1.14	0.71	0.04	0.62	1.21	0
Currency Exchange Gain (Loss)	-0	-0	-0	-0.01	-0	0
Other Non-Operating Income	0.83	0.54	0.39	0.31	-0.01	0.61
EBT Excluding Unusual Items	2.52	1.11	0.2	0.7	0.81	0.51
Gain (Loss) on Sale of Investments	-	-	-0.07	-	-0.01	-0.94
Gain (Loss) on Sale of Assets	0	0	-	-	-	0.1
Asset Writedown	1.16	1.16	1.01	0.42	0.61	-0.23
Pretax Income	3.69	2.27	1.14	1.13	1.41	-0.55
Income Tax Expense	0.02	0.02	0.01	0.01	0.02	-
Earnings From Continuing Operations	3.67	2.24	1.13	1.12	1.39	-0.55
Net Income to Company	3.67	2.24	1.13	1.12	1.39	-0.55
Net Income	3.67	2.24	1.13	1.12	1.39	-0.55
Net Income to Common	3.67	2.24	1.13	1.12	1.39	-0.55
Net Income Growth	149.09%	98.02%	1.08%	-19.54%	-	-
Basic Shares Outstanding	109	109	109	109	109	109
Diluted Shares Outstanding	109	109	109	109	109	109
EPS (Basic)	0.03	0.02	0.01	0.01	0.01	-0.01
EPS (Diluted)	0.03	0.02	0.01	0.01	0.01	-0.01
EPS Growth	149.09%	98.02%	1.08%	-19.54%	-	-
Dividend Per Share	-	-	0.004	0.008	0.010	0.007
Dividend Growth	-	-	-50.65%	-19.79%	43.28%	4.69%
Operating Margin	79.18%	2.07%	-33.83%	-36.32%	-162.93%	-21.01%
Profit Margin	379.20%	301.13%	239.01%	247.64%	604.23%	-117.92%
EBITDA	-	0.02	-0.16	-0.16	-0.37	-0.1
EBITDA Margin	-	2.09%	-33.58%	-36.07%	-162.00%	-20.62%
D&A For Ebitda	-	0	0	0	0	0
EBIT	0.77	0.02	-0.16	-0.16	-0.38	-0.1
EBIT Margin	79.18%	2.07%	-33.83%	-36.32%	-162.93%	-21.01%
Effective Tax Rate	0.47%	1.00%	0.76%	0.46%	1.19%	-

Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.